HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
LeadSI
Supernova Invest
Activity from announced rounds
Activity in this selectionOct 21, 2026 · Jul 24, 2026
Supernova Invest is the French deep-technology manager whose own materials identify Quobly and HighLife.
Recorded funding activity
HighLife develops a transcatheter heart-valve system. Exein secures devices, while Moa discovers herbicides. Named seed funds remain separate from the manager-level history.
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $361.7M 2 disclosed · full round size, not this investor’s share